Table 1.
Day 0–7 | Day 0–7 (All Measures Below to Be Completed within 2 Days) | Day 14–42 | |
---|---|---|---|
Informed consent (patients, healthy individuals) | ○ | ||
Background information (patients, healthy individuals) | ○ | ||
M.I.N.I. (patients, healthy individuals) | ○ | ||
JART-25 (patients, healthy individuals) | ○ | ||
PANSS (patients) | ○ | ||
BNSS (patients) | ○ | ||
DPB (patients *) | ○ | ||
BACS-J (patients *) | ○ | ||
UPSA-B (patients *) | ○ | ||
SLOF (patients *) | ○ | ||
Japanese versions of social cognition measures (patients *, healthy individuals) | ○ | ○ | |
Scale of subjective difficulty of social cognition measures (patients *, healthy individuals) | ○ | ||
Gut microbiota (patients, healthy individuals) | □ | ||
Duration (min) | 40 | 180 (Healthy individuals: 80) |
70 |
○: mandatory, □: optional. * Measures with an asterisk next to “patients” are conducted with patients for the purposes of this study, while measures without an asterisk are conducted as part of standard clinical practice. BACS-J, Brief Assessment of Cognition for Schizophrenia, Japanese Version; BNSS, Brief Negative Symptom Scale; DPB, Defeatist Performance Beliefs; JART-25, Japanese Adult Reading Test-25; M.I.N.I., Mini-International Neuropsychiatric Interview; PANSS, Positive and Negative Syndrome Scale; SLOF, Specific Levels of Functioning Scale; UPSA-B, University of California, San Diego Performance-based Skill Assessment—Brief.